Red Light Holland subsidiary signs psilocybin supply deal with Paris hospital Jun 8, 2026 07:32AM
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in France Jun 8, 2026 07:30AM
Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinica Jun 4, 2026 07:30AM
Red Light Holland Expands New Zealand Partnership with Allu Therapeutics to Advance Access to Filament Health's GMP-Compliant PEX010 Botanical Psilocybin Drug Candidate May 25, 2026 08:40AM
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Advances PEX010 Clinical Footprint with New Canadian Academic Studies in Palliative Care, Bipolar II Depression, and Healthy Adult Mechani May 14, 2026 08:30AM
View Older Stories

May 13, 2026 09:14AM Red Light Holland shareholders approve name change, CFO resigns
May 13, 2026 09:12AM Red Light Holland Announces Shareholder Approval of Name Change and Announces Voting Results from 2026 Annual General and Special Meeting of Shareholders
May 8, 2026 07:30AM Red Light Holland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with Filament Health Holding the Exclusive License to the Data and Intell
May 7, 2026 07:30AM Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutions
May 4, 2026 08:30AM Red Light Holland Announces Intention to Rebrand
Apr 30, 2026 07:37AM Red Light Holland completes acquisition of Filament Health
Apr 30, 2026 07:30AM Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution
Apr 29, 2026 07:30AM Red Light Holland Announces Filament Health Obtains Final Order for Proposed Arrangement
Apr 27, 2026 07:30AM Red Light Holland Announces Filament Health Shareholder Approval of Acquisition
Apr 24, 2026 08:26AM Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments
Apr 20, 2026 07:30AM Red Light Holland Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy using Filament Health's Patented PEX010 Botanical Drug Candidate
Apr 7, 2026 07:30AM Red Light Holland Reports Continued Expansion of Filament Health's PEX010 Clinical Network with New License Agreements and Research Shipments
Apr 1, 2026 09:20AM Red Light Holland to Support University of California San Francisco's Global Psychedelic Study Through Filament Health's Clinical Network
Mar 23, 2026 08:15AM Red Light Holland Announces Filament Health Obtains Interim Order for Proposed Arrangement
Mar 18, 2026 08:15AM Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate
Mar 11, 2026 07:32AM Red Light Holland to acquire Filament Health in all-share deal
Mar 11, 2026 07:30AM RETRANSMISSION: Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation
Mar 10, 2026 04:42PM Red Light Holland to acquire Filament Health in all-share deal
Mar 10, 2026 04:40PM Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation
Mar 3, 2026 08:00AM Red Light Holland Reports Third Quarter 2026 Results and Provides Corporate Update
Dec 1, 2025 04:30PM Red Light Holland Reports Second Quarter 2026 Results and Provides Corporate Update
Nov 19, 2025 07:45AM Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives Second, Larger 5kg Psilocybin Shipment via USA Controlled Substances Import Permit
Nov 11, 2025 08:39AM Red Light Holland's Wholly Owned Subsidiary Happy Caps Expands Safeway Partnership to 123 Stores Across the U.S. Pacific Northwest, in Time for American Thanksgiving
Oct 14, 2025 08:34AM Red Light Holland Secures Second United States Controlled Substances Import Permit for the Company's Psilocybin Through FDA-Compliant, DEA-Registered Partner Irvine Labs
Sep 30, 2025 08:06AM Red Light Holland Receives Official Psilocybin COA Through FDA-Compliant, DEA-Registered Partner, Irvine Labs, USA
Sep 4, 2025 08:01AM Red Light Holland's Wholly Owned Subsidiary Happy Caps Mushroom Farm Secures Continued Safeway Partnership to 123 Stores Across Two Seasonal Programs in the U.S.
Aug 28, 2025 07:40AM Red Light Holland Reports First Quarter 2026 Results
Aug 26, 2025 08:23AM Red Light Holland Updates Bitcoin Balance Sheet Strategy
Aug 20, 2025 08:43AM Red Light Holland Applauds HHS Review of Psilocybin Rescheduling Petition, Expresses Optimism for Reversal of Schedule I Classification
Aug 18, 2025 08:16AM Red Light Holland Receives Initial Third-Party Psilocybin Testing Results via FDA-Compliant, DEA-Registered Partner, Irvine Labs
Jul 30, 2025 08:05AM Red Light Holland CEO Todd Shapiro Invited by Blockchain Futurist Conference for Fireside Chat and Panel Hosting
Jul 29, 2025 07:30AM Red Light Holland Reports 2025 Audited Year-End Results - Demonstrates Continued Fiscal Discipline, Strategic Growth, and Psilocybin R&D Expansion
Jul 28, 2025 09:19AM Red Light Holland Provides Timing for 2025 Audited Year-End Results and Announces Live Q&A
Jul 25, 2025 08:33AM Red Light Holland Selects Arch Public for Bitcoin Purchases on Recommendation from Advisor Scott Melker
Jul 15, 2025 08:03AM Red Light Holland Announces Bitcoin Balance Sheet Strategy and Names Scott Melker as Lead Cryptocurrency Advisor
Jul 14, 2025 07:45AM Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives First Global Shipment of Psilocybin from Company's Netherlands Facility via USA Controlled Substances Permit
Jul 2, 2025 08:12AM Red Light Holland Announces Dr. Robin Carhart-Harris as Scientific Advisor
Jun 19, 2025 08:05AM Red Light Holland Partners with Arizona State University to Support Groundbreaking Psychedelic Genome Project (PGP) Research Study
May 21, 2025 08:18AM Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Granted United States Controlled Substances Import Permit for the Company's Raw Psilocybin Truffles
May 13, 2025 07:30AM Red Light Holland Announces Happy Caps 2kg "Mega Block" Mushroom Home Grow Kits Are Now Available in Costco Stores Across Canada
May 12, 2025 07:30AM Red Light Holland's Wholly Owned Subsidiary Happy Caps Launches Presales of Health Canada Approved Functional Mushroom Gummies
Apr 22, 2025 08:59AM Red Light Holland's Wholly Owned Subsidiary Happy Caps Mushroom Farm Officially Launches with Albertsons - 66 Safeway Stores Across Oregon and Washington, United States
Apr 15, 2025 08:50AM Red Light Holland's Partner FDA-Compliant and DEA-Registered Irvine Labs Receives 2025 Psilocybin DEA Quotas, Including Import Quota
Apr 7, 2025 08:15AM Red Light Holland's Wholly Owned Subsidiary Happy Caps Mushroom Farm Secures Purchase Order with Albertsons - Safeway for First U.S. Retail Launch
Mar 19, 2025 07:35AM Red Light Holland Appoints Michael Galloro to Board of Directors
Mar 13, 2025 08:00AM Red Light Holland Announces Costco Canada Signals Another Expanded Commitment to Happy Caps Mushroom Home Grow Kits
Feb 26, 2025 07:50AM Red Light Holland Reports Third Quarter 2025 Results
Feb 4, 2025 08:10AM Red Light Holland's Wholly Owned Subsidiary Happy Caps Receives Health Canada Approval For, Unique Mushroom Gummy Formula, Functional Mushroom Gummies
Jan 30, 2025 08:15AM Red Light Holland, in Partnership with FDA-Compliant and DEA-Registered Irvine Labs, Updates R&D Plan Focused On Commercialization
Jan 22, 2025 08:02AM Red Light Holland Appoints Keith Li as Chief Financial Officer and Provides Corporate Updates
View Older Stories